Toxic or drug-induced granulomatous reactions;Granulomatoses d'origine médicamenteuse ou toxique

Revue de Medecine Interne

Volumn 29, Issue 1, 2008, Pages 33-38

  Vital Durand, D ^a   Durieu, I ^a   Rousset, H ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Drug induced; Granulomatous disease; Sarcoidosis; Toxic reaction

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; BCG VACCINE; ILLICIT DRUG;

BCG VACCINATION; BERYLLIOSIS; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG INTOXICATION; ENVIRONMENTAL EXPOSURE; FOREIGN BODY; GRANULOMATOSIS; HUMAN; IMMUNOTHERAPY; KIDNEY; LIVER; LUNG; OCCUPATIONAL EXPOSURE; SARCOIDOSIS; SHORT SURVEY; SKIN;

ALLOPURINOL; ANTIMETABOLITES; BCG VACCINE; BERYLLIOSIS; GRANULOMA; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; SARCOIDOSIS; SKIN DISEASES;

EID: 37349018795     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.09.039     Document Type: Short Survey

References (70)

1. Papo T., and Piette J.-C. Granulomatoses systémiques. In: Kahn M.F., Peltier A.P., Meyer O., and Piette J.-C. (Eds). Maladies et syndromes systémiques (2000), Flammarion Médecines-Sciences, Paris 1189-1206
2. El-Zammar O.A., and Katzenstein A.L. Pathological diagnosis of granulomatous lung disease: a review. Histopathology 50 (2007) 289-310
3. Singh N., and Davis G.S. Review: occupational and environmental lung disease. Curr Opin Pulm Med 8 (2002) 117-125
4. Kelleher P., Pacheco K., and Newman L.S. Inorganic dust pneumonias: the metal-related parenchymal disorders. Environ Health Perspect 108 suppl 4 (2000) 685-696
5. Rossman M.D., and Keider M.E. Is chronic beryllium disease sarcoidosis of known etiology?. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 104-109
6. Marchand-Adam S., Guillon F., Brauner M., and Valeyre D. Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (part 2). Rev Mal Respir 22 (2005) 271-287
7. Newman L.S. Metals that cause sarcoidosis. Semin Respir Infect 13 (1998) 212-220
8. Muller-Quernheim J., Gaede K.I., Fireman E., and Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27 (2006) 1190-1195
9. Infante P.F., and Newman L.S. Beryllium exposure and chronic beryllium disease. Lancet 363 (2004) 415-416
10. Fireman E., Goshen M., Ganor E., Spirer Z., and Lerman Y. Induced sputum as an additional tool in the identification of metal-induced sarcoid-like reaction. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 152-156
11. Safirstein B.H., Klukowicz A., Miller R., and Teirstein A. Granulomatous pneumonitis following exposure to the World Trade Center collapse. Chest 123 (2003) 301-304
12. Bodokh I., Brun P., Mayaffre C., Majcwrczyk N., and Montagne M. Cutaneous sarcoidosis secondary to inhalation of wall insulating material particles. Ann Dermatol Venereol 125 (1998) 182-184
13. Audigier C., Nesme P., Perol M., and Guérin J.C. Rare pulmonary complication in intravesical BCG treatment. Rev Mal Respir 17 (2000) 679-681
14. Kamphuis J.T., Buiting A.G., Misere J.F., van Berge Henegouwen D.P., van Soolingen D., and Rensma P.L. BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations. Neth J Med 58 (2001) 71-75
15. Midturi J., Sierra-Hoffman M., Hurley D., Winn R., Beissner R., and Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature. Clin Infect Dis 39 (2004) 1724-1729
16. Butnor K.J. Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 29 (2005) 976-979
17. Verschueren K., Van Essche E., Verschueren P., Taelman V., and Westhovens R. Development of sarcoidosis in etanercept-treated rhumatoid arthritis patients. Clin Rheumatol 34 (2007) 648-649
18. Kudrin A., Chilvers E.R., Ginawi A., Hazleman B.L., Griffiths M.H., Thiru S., et al. Sarcoid-like granulomatous disease following etanercept treatment for rheumatoid arthritis. J Rheumatol 34 (2007) 648-649
19. Foulon G., Wislez M., Naccache J.M., Blanc F.X., Rabbat A., Israel-Biet D., et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38 (2004) 418-425
20. French M.A., Price P., and Stone S.F. Immune restoration disease after antiretroviral therapy. AIDS 18 (2004) 1615-1627
21. Patel A.M., Ryu J.H., and Reed C.E. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 108 (2001) 661-670
22. Thaon I., Reboux G., Moulonguet S., and Dalphin J.C. Occupational hypersensitivity pneumonitis. Rev Mal Respir 23 (2006) 705-725
23. Tomashefski Jr. J.F., and Felo J.A. The pulmonary pathology of illicit drug and substance abuse. Curr Diag Pathol 10 (2004) 413-426
24. Hirche T.O., Lambrecht E., and Wagner T.O. Crack-syndrome: the pulmonary complications of inhaled cocaine. A review a propos a case report. Pneumologie 56 (2002) 684-688
25. Mukhopadhyay S., and Katzenstein A.-L.A. Pulmonary disease due to aspiration of food and other particulate matter. A clinico-pathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol 31 (2007) 752-759
26. Kleiner D.E. Granulomas in the liver. Semin Diagn Pathol 23 (2006) 161-169
27. McCluggage W.G., and Sloan J.M. Hepatic granulomas in Northern Ireland: a thirteen year review. Histopathol 25 (1994) 219-228
28. Gaya D.R., Thorburn D., Oien K.A., Morris A.J., and Stanley A.J. Hepatic granulomas: a 10 year single center experience. J Clin Pathol 56 (2003) 850-853
29. Dourakis S.P., Saramadou R., Alexopoulou A., Kafiri G., Deutsch M., Koskinas J., et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 19 (2007) 101-104
30. e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 28 (2004) 720-759
31. Sartin J.S., and Walker R.C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin Proc 66 (1991) 914-918
32. Dhawan M., Agrawal R., Ravi J., Gulati S., Silverman J., Nathan G., et al. Rosiglitazone-induced granulomatous hepatitis. J Clin Gastroenterol 34 (2002) 582-584
33. Saw D., Pitman E., Maung M., Savasatit P., Wasserman D., and Yeung C.K. Granulomatous hepatitis associated with glyburide. Dig Dis Sci 41 (1996) 322-325
34. Toft E., Vyberg M., and Therkelsen K. Diltiazem-induced granulomatous hepatitis. Histopathol 18 (1991) 474-475
35. Ruiz-Valverde P., Zafon C., Segarra A., Ribera R., and Piera L. Ticlopidine-induced granulomatous hepatitis. Ann Pharmacother 29 (1995) 633-634
36. Knobel B., Buyanowsky G., Dan M., and Zaidel L. Pyrazinamide-induced granulomatous hepatitis. J Clin Gastroenterol 24 (1997) 264-266
37. Bjornsson E., Olsson R., and Remotti H. Norfloxacin-induced eosinophilic necrotizing granulomatous hepatitis. Am J Gastroenterol 95 (2000) 3662-3664
38. Colle I., Naegels S., Hoorens A., and Hautekeete M. Granulomatous hepatitis due to mebendazole. J Clin Gastroenterol 28 (1999) 44-45
39. Jorge O.A., and Jorge A.D. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 97 (2005) 115-124
40. Lindgren A., Aldenborg F., Norkrans G., Olaison L., and Olsson R. Paracetamol-induced cholestatic and granulomatous liver injuries. J Intern Med 24 (1997) 435-439
41. Propst A., Propst T., Dietze O., Kathrein H., Judmeier G., and Vogel W. Development of granulomatous hepatitis during treatment with interferon-alpha 2b. Dig Dis Sci 40 (1995) 2117-2118
42. Veerabagu M.P., Finkelstein S.D., and Rabinovitz M. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha. Dig Dis Sci 42 (1997) 1445-1448
43. Van Outryve S.M., Francque S.M., Gentens P.A., De Pauw F.F., Van den Bogaert E., Van Marck E.A., et al. Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinoma. Eur J Gastroenterol Hepatol 16 (2004) 1027-1032
44. Steg A., Leleu C., Debré B., Boccon-Gibod L., and Sicard D. Systemic bacillus Calmette-Guérin infection, "BCG-itis", in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer. Eur Urol 16 (1989) 161-164
45. Urban R.M., Jacobs J.J., Tomlinson M.J., Gavrilovic J., Black J., and Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 82 (2000) 457-476
46. Peoc'h M., Pasquier D., Ducros V., Moulin C., Bost F., Faure C., et al. Systemic granulomatous reaction in hip prosthesis. A propos of 2 anatomoclinical cases. Rev Chir Orthop Reparatrice Appar Mot 82 (1996) 564-567
47. Gatti A.M., Ballestri M., and Bagni A. Granulomatosis associated to porcelaine wear debris. Am J Dent 15 (2002) 369-372
48. Gatti A.M., and Rivasi F. Biocompatibility of micro- and nanoparticles. Part I: in liver and kidney. Biomaterials 23 (2002) 2381-2387
49. Lam C.W., James T.L., McCluskey R., Arepalli S., and Hunter R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36 (2006) 189-217
50. Ishak K.G., and Zimmerman H.J. Drug-induced and toxic granulomatous hepatitis. Bailleres Clin Gastroenterol 2 (1988) 463-480
51. Viero R.M., and Cavallo T. Granulomatous interstitial nephritis. Hum Pathol 26 (1995) 1347-1353
52. Bijol V., Mendez G.P., Nose V., and Rennke H.G. Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution. Int J Surg Pathol 14 (2006) 57-63
53. Chaufer M. Les granulomatoses rénales. Thèse de médecine de l'université de Lyon. 2006 : 139 pp.
54. Fillastre J.P., Legallicier B., Godin M., and Le Roy F. Néphropathies interstitielles d'origine médicamenteuse ou toxique. Presse Med 26 (1997) 477-484
55. Baker R.J. The changing profile of acute tubulo-interstitial nephritis. Nephrol Dial Transplant 19 (2004) 8-11
56. Torpey N., Barker T., and Ross C. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant 19 (2004) 1441-1446
57. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int 60 (2001) 804-817
58. Allon M., Lopez E.J., and Min K.W. Acute renal failure due to ciprofloxacine. Arch Intern Med 150 (1990) 2187-2189
59. Franklin T.J. Opportunities for the discovery of novel therapies for fibrotic diseases. Exp Nephrol 3 (1995) 143-147
60. World M.J., Stevens P.E., Ashton M.A., and Rainford D.J. Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant 11 (1996) 614-621
61. Do Sameiro Faria M., Sampaio S., Faria V., and Carvalho E. Nephropathy associated with heroin abuse in Caucasian patients. Nephrol Dial Transplant 18 (2003) 2308-2313
62. Izikson L., and English J.C. Noninfectious granulomatous diseases: an update. Adv Dermatol 22 (2006) 31-53
63. Murray C.A., Dekoven J., and Spaner D.E. Foreign body granuloma: a new manifestation of immune restoration disease. J Cutan Med Surg 7 (2003) 38-42
64. Ghislanzoni M., Bianchi F., Barbareschi M., and Alessi E. Cutaneous granulomatous reaction to injectable hyaluronic acid gel. Br J Dermatol 154 (2006) 755-758
65. Lombardi T., Samson J., Plantier F., Husson C., and Kuffer R. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med 33 (2004) 115-120
66. Travis W.D., Balogh K., and Abraham J.L. Silicone granulomas: report of three cases and review of the literature. Hum Pathol 16 (1985) 19-27
67. Daley T.D., and Wysocki G.P. Foreign body gingivitis: an iatrogenic disease?. Oral Surg Oral Med Oral Pathol 69 (1990) 708-712
68. Carlson J.A., Schuzer P., Pattison T., Del Rosario A., and Mihm Jr. M.C. Sarcoidal foreign-body granulomatous dermatitis associated with ophtalmologic drops. Am J Dermatopathol 20 (1998) 175-178
69. Nikkels A.F., Nikkels-Tassoudji N., and Piérard G.E. Cutaneous adverse reactions following anti-infective vaccinations. Am J Clin Dermatol 6 (2005) 79-87
70. Magro C.M., Crowson A.N., and Schapiro B.L. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 25 (1998) 72-78